Optimizing HIV PrEP Through Shared Decision Making

NACompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

May 24, 2018

Study Completion Date

May 24, 2018

Conditions
Pre-Exposure Prophylaxis
Interventions
BEHAVIORAL

PrEP Decision Aid

All participants will participate in a simulated or actual clinical visit with a healthcare provider. During this visit, they will review the Decision Aid which will give them an HIV risk score and ask questions about their values. The goal of these visits will be to make an informed decision about whether or not to begin using PrEP.

Trial Locations (2)

02215

Beth Israel Deaconess Medical Center, Boston

The Fenway Institute, Boston

All Listed Sponsors
collaborator

The Fenway Institute

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER

NCT03019770 - Optimizing HIV PrEP Through Shared Decision Making | Biotech Hunter | Biotech Hunter